CB-012
CB12A
Phase 1 small_molecule terminated
Quick answer
CB-012 for Acute Myeloid Leukemia, in Relapse is a Phase 1 program (small_molecule) at Caribou Biosciences with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Caribou Biosciences
- Indication
- Acute Myeloid Leukemia, in Relapse
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated